Israel Englander United Therapeutics Corp Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in United Therapeutics Corp stock. As of the latest transaction made, Millennium Management LLC holds 3,900 shares of UTHR stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,900

Previous 43,677 91.07%

Holding current value

$1.55 Million

Previous $10 Million 87.62%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $13.5 Million - $18.9 Million	59,354 Added 135.89%	103,031 $32.8 Million
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $15.9 Million - $18.8 Million	-75,532 Reduced 63.36%	43,677 $10 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $2.59 Million - $3.09 Million	-12,038 Reduced 9.17%	119,209 $26.2 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $26 Million - $29.5 Million	-126,594 Reduced 49.1%	131,247 $29 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $53.3 Million - $69.2 Million	-250,432 Reduced 49.27%	257,841 $57.7 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $15.1 Million - $20.6 Million	-73,437 Reduced 12.62%	508,273 $141 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $20.4 Million - $24.5 Million	100,312 Added 20.84%	581,710 $122 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $17.9 Million - $24.7 Million	-102,400 Reduced 17.54%	481,398 $113 Million
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $29.4 Million - $37.8 Million	176,658 Added 43.39%	583,798 $105 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $7.51 Million - $8.81 Million	40,768 Added 11.13%	407,140 $88 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $33.6 Million - $40.1 Million	-186,767 Reduced 33.76%	366,372 $67.6 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $26 Million - $32.3 Million	152,287 Added 37.99%	553,139 $99.2 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $31.9 Million - $36.3 Million	-207,341 Reduced 34.09%	400,852 $67.1 Million
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $13.1 Million - $19.6 Million	128,947 Added 26.91%	608,193 $92.3 Million
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $2.58 Million - $3.13 Million	25,875 Added 5.71%	479,246 $48.4 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $36.7 Million - $49.8 Million	-396,175 Reduced 46.63%	453,371 $54.9 Million
Q1 2020 May 14, 2020	SELL	$79.39 - $115.35 $20.9 Million - $30.4 Million	-263,377 Reduced 23.67%	849,546 $80.6 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $44 Million - $53.6 Million	-562,199 Reduced 33.56%	1,112,923 $98 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $994,232 - $1.14 Million	13,283 Added 0.8%	1,675,122 $134 Million
Q2 2019 Aug 15, 2019	BUY	$76.06 - $120.81 $125 Million - $199 Million	1,644,968 Added 9750.27%	1,661,839 $130 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $431,868 - $685,959	5,678 Added 50.73%	16,871 $2.3 Million
Q1 2019 May 14, 2019	SELL	$107.15 - $126.84 $2.71 Million - $3.21 Million	-25,270 Reduced 69.3%	11,193 $1.31 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $9.61 Million - $12.2 Million	-94,789 Reduced 72.22%	36,463 $3.97 Million
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $9.59 Million - $10.9 Million	84,262 Added 179.32%	131,252 $16.8 Million
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $12.2 Million - $14.2 Million	-120,321 Reduced 71.91%	46,990 $5.32 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $8.51 Million - $12.1 Million	-79,423 Reduced 32.19%	167,311 $18.8 Million
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $8.24 Million - $10.5 Million	-69,513 Reduced 21.98%	246,734 $36.5 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $36.2 Million - $43.3 Million	316,247	316,247 $37.1 Million

Others Institutions Holding UTHR

# of Institutions

644

Shares Held

44.9M

Call Options Held

368K

Put Options Held

410K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $18.1B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account